Form 4: Assembly Biosciences Executive Sells Shares to Cover Tax Obligations

Nicole S. White, Chief Manufacturing Officer of Assembly Biosciences, sold 172 shares of common stock to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Summary

• On May 23, 2024, Nicole S. White, the Chief Manufacturing Officer of Assembly Biosciences, sold 172 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
• The shares were sold at a weighted average price of $14.9338, with individual transactions ranging from $14.74 to $15.20.
• Following the transaction, White directly owns 12,853 shares of Assembly Biosciences common stock.
• The sale was mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a 'sell-to-cover' transaction.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine stock sale to cover tax obligations. It doesn't inherently convey positive or negative sentiment regarding the company's performance or outlook.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This particular filing reflects a common practice of executives selling shares to cover tax obligations related to equity compensation.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates